Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (1)
Austria (1)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
China (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
Thailand (1)
The Phillippines (1)
United Kingdom (3)
Vietnam (2)
STADA: Legal action against STADA’s Serbian subsidiary has been resolved
STADA: STADA strengthens aesthetics area through cooperation with CROMA-PHARMA and at the same time secures access to Botulinumtoxin A
STADA: STADA signs contract to purchase Argentinian generics producer Vannier
One in two Germans do not know enough about their health
STADA: Nine-month results show strong development in the third quarter – outlook for 2015 confirmed
STADA: Appointment of Helmut Kraft as Chief Financial Officer extended
Third Capital Markets Day – STADA commits to Russian market in Saint Petersburg
STADA Press Conference: Growth through Internationalization
STADA: Clarification of the media's incorrect presentation of the remuneration for the STADA Chairman of the Executive Board
STADA: Executive Board contract of Chairman of the Executive Board Hartmut Retzlaff extended by five years
STADA expands branded product portfolio with addition of food intolerances area
New Russian Consul General visits STADA as first German company
STADA and Richter signed a license and distribution agreement for biosimilar Pegfilgrastim
STADA: Figures for the first half of 2015 benefit from substantially improved development in Q2/2015 – Central Europe as well as Asia/Pacifi…
STADA Group makes further investment in Serbian location
STADA: Executive Board gives a positive summary of financial year 2014 at the Annual General Meeting and confirms outlook for 2015
STADA: Sales and earnings key figures in the first quarter of 2015 not as significantly burdened by CIS crisis as expected – Positive trend …
STADA: Successful refinancing at favorable conditions through the placement of a further corporate bond in the total amount of Euro 300 mill…
STADA: Sales and earnings targets for 2014 at Group level met – crisis in the market region CIS/Eastern Europe requires impairments on goodw…
Lothar Guske: “Ebola rapid test positively influences both patient and quarantine management”
STADApharm launches device-independent rapid test for the detection of Ebola infections
STADA: Russian STADA subsidiary strengthens branded product portfolio in the men's health area